Engineering mesoporous silica nanoparticles towards oral delivery of vancomycin
Vancomycin (Van) is a key antibiotic of choice for the treatment of systemic methicillin
resistant Staphylococcus aureus (MRSA) infections. However, due to its poor membrane …
resistant Staphylococcus aureus (MRSA) infections. However, due to its poor membrane …
Engineering mesoporous silica nanoparticles towards oral delivery of vancomycin
J Ndayishimiye, Y Cao, T Kumeria… - Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Vancomycin (Van) is a key antibiotic of choice for the treatment of systemic methicillin
resistant Staphylococcus aureus (MRSA) infections. However, due to its poor membrane …
resistant Staphylococcus aureus (MRSA) infections. However, due to its poor membrane …
[引用][C] Engineering mesoporous silica nanoparticles towards oral delivery of vancomycin
J Ndayishimiye, Y Cao, T Kumeria… - Journal of …, 2021 - espace.library.uq.edu.au
Vancomycin (Van) is a key antibiotic of choice for the treatment of systemic methicillin
resistant Staphylococcus aureus (MRSA) infections. However, due to its poor membrane …
resistant Staphylococcus aureus (MRSA) infections. However, due to its poor membrane …
Engineering mesoporous silica nanoparticles towards oral delivery of vancomycin.
J Ndayishimiye, Y Cao, T Kumeria… - Journal of Materials …, 2021 - europepmc.org
Vancomycin (Van) is a key antibiotic of choice for the treatment of systemic methicillin
resistant Staphylococcus aureus (MRSA) infections. However, due to its poor membrane …
resistant Staphylococcus aureus (MRSA) infections. However, due to its poor membrane …